医学
炎症
药品
药理学
药物开发
临床试验
生物信息学
病理
临床实习
血管
免疫学
血管平滑肌
血管疾病
作者
Fan-shun Zhang,He Cy,Yanjun Yin,Zhihua Wang,Xiumei Wu,Danielle Kamato,Ruixue Leng,Jiang-Yun Luo,Jianping Weng,S. Xu
出处
期刊:Circulation Research
[Lippincott Williams & Wilkins]
日期:2026-01-09
卷期号:138 (4): e326508-e326508
标识
DOI:10.1161/circresaha.125.326508
摘要
Taken together, these findings support the concept that neratinib could be tested as a repurposed drug for vascular inflammation and atherosclerosis, thereby streamlining efforts to translate preclinical discoveries to clinical testing in humans.
科研通智能强力驱动
Strongly Powered by AbleSci AI